| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $3,095,384 ) |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 001 | 4 | NIH | 1/7/2025 | $534,040 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM152716 | Development of polymer-based cell culture substrates for correlative light and electron microscopy (CLEM) | 001 | 2 | NIH | 7/25/2025 | $303,826 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 002 | 6 | NIH | 7/17/2025 | $100,000 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI168097 | Modeling the influence of temperature on the evolution of vector-virus interactions | 000 | 4 | NIH | 2/13/2025 | $470,383 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 002 | 4 | NIH | 8/5/2025 | $59,338 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 000 | 4 | NIH | 1/28/2025 | $183,438 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI181948 | Characterization of a novel kin recognition system in mycobacteria | 000 | 2 | NIH | 12/12/2024 | $442,353 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI187284 | Therapeutic potential of mycobacteriophage LysB against Mycobacterium abscessus infections | 000 | 1 | NIH | 7/18/2025 | $689,051 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 3 | HRSA | 7/2/2025 | $130,578 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 3 | HRSA | 7/2/2025 | $214,422 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001342 | Extending New York State?s Biomonitoring Program for Assessing Disproportionate Exposure to Environmental Chemicals among Urban and Rural Communities | 01 | 1 | CDC | 10/21/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 001 | 6 | NIH | 7/16/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 000 | 6 | NIH | 12/12/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 000 | 3 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI155473 | Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistance | 000 | 5 | NIH | 7/14/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI110112 | Latitudinal Landscape Genomics and Ecology of Anopheles Darlingi | 000 | 10 | NIH | 8/4/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 002 | 5 | FDA | 5/28/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 001 | 5 | FDA | 1/8/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 000 | 5 | FDA | 11/7/2024 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 04 | 2 | HRSA | 2/26/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 03 | 2 | HRSA | 1/6/2025 | $0 |
| | 2025 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM152716 | Development of polymer-based cell culture substrates for correlative light and electron microscopy (CLEM) | 000 | 1 | NIH | 12/17/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 007 | 2 | NIH | 3/26/2025 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 005 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 003 | 2 | NIH | 11/4/2024 | $15,988 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144372 | Dissecting and connecting the SigM stimulus and ESX-4 secretory response in mycobacteria | 000 | 2 | NIH | 7/25/2025 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R56AI168356 | RNA regulation associated with mcr11-abmR locus in M. tuberculosis | 000 | 1 | NIH | 8/8/2025 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM139277 | Systematic Discovery and Analysis of Small Proteins and Small ORFs in Mycobacteria | 000 | 4 | NIH | 8/5/2025 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM130298 | Efficiency and fidelity in mitotic spindle assembly | 001 | 5 | NIH | 5/6/2025 | -$69 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM130298 | Efficiency and fidelity in mitotic spindle assembly | 000 | 5 | NIH | 11/8/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 001 | 6 | NIH | 12/19/2024 | $111,150 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2023 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 009 | 2 | NIH | 4/7/2025 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 006 | 2 | NIH | 3/26/2025 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 004 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R21AI154680 | Leveraging a transcription regulatory network to understand Salmonella invasion of host epithelial cells | 000 | 2 | NIH | 6/16/2025 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U1W42317 | Long-term Follow-up for SCID and other NBS Conditions | 04 | 2 | HRSA | 6/20/2025 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R03AI150987 | STnc520, a virulence-associated regulatory RNA in Salmonella Typhimurium | 000 | 2 | NIH | 4/15/2025 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 008 | 2 | NIH | 4/7/2025 | $0 |
| | 2025 | 2021 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
| | 2025 | 2021 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 000 | 5 | NIH | 12/19/2024 | -$111,150 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 002 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 001 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 000 | 1 | NIH | 11/4/2024 | -$15,988 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI125190 | Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2020 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 03 | 5 | CDC | 12/18/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $7,057,414 ) (Continued on the next page) |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI181948 | Characterization of a novel kin recognition system in mycobacteria | 000 | 1 | NIH | 1/30/2024 | $471,223 |
|
